ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant
NCT03932643
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Interventions
DRUG:
ONC-201
Sponsor
University of Nebraska